ArticleAsian journal of pharmaceutical sciences2026
Carrier-free doxorubicin nanomedicine integrates chemotherapy and chemodynamic therapy to achieve anti-tumor efficacy.
Min Liu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.